Work

Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy

Year: 2023

Type: article

Abstract: To the Editor,Since the implementation of the median MELD at transplant minus three (MMaT-3) policy in May 2019, the disparity in prioritization for liver transplant (LT) among patients with HCC and non-HCC has significantly narrowed.Although there is no significant change in overall waitlist dropout, patients with HCC have experienced a decrease in LT

Source: Liver Transplantation

DOI: 10.1097/lvt.0000000000000167

Authors: Anjiya Shaikh, Tzu-Hao Lee, Nicole E. Rich, Jihane N. Benhammou, Peter Lymberopoulos, Vatche G. Agopian, Donghee Kim, Aijaz Ahmed, Ruben Hernaez, Carl L. Berg, John Goss, Abbas Rana, Fasiha Kanwal, George Cholankeril

Institutions: University of Connecticut, UConn Health, Baylor College of Medicine, The University of Texas Southwestern Medical Center, University of California, Los Angeles, SUNY Downstate Health Sciences University, Stanford Medicine, Stanford University, Duke University, Michael E. DeBakey VA Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Prevention and Research Institute of Texas, American Association for the Study of Liver Diseases, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1147702603, G1897178486, G2036276671, G2849904280, G6182568868, Reducing Disparities in the Risk of Hepatocellular Cancer, G6538143809, Clinical Validation Center for Hepatocellular Carcinoma

OpenAlex ID: W4367669270

FWCI: 0.844

Cites: 6

Cited by: 6

Related to: 10